review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.EJRAD.2006.06.021 |
P698 | PubMed publication ID | 17005349 |
P2093 | author name string | Marie-France Bellin | |
P433 | issue | 3 | |
P921 | main subject | contrast agent | Q6849688 |
P304 | page(s) | 314-323 | |
P577 | publication date | 2006-09-26 | |
P1433 | published in | European Journal of Radiology | Q15759696 |
P1476 | title | MR contrast agents, the old and the new. | |
P478 | volume | 60 |
Q36625800 | (89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer |
Q36747329 | A choline derivate-modified nanoprobe for glioma diagnosis using MRI. |
Q48920812 | A novel ascorbic acid-resistant nitroxide in fat emulsion is an efficient brain imaging probe for in vivo EPR imaging of mouse. |
Q47759079 | A tailored nanosheet decorated with a metallized dendrimer for angiography and magnetic resonance imaging-guided combined chemotherapy |
Q36028884 | A transferrin-target magnetic/fluorescent dual-mode probe significantly enhances the diagnosis of non-small cell lung cancer. |
Q36836266 | Abdominal MRI advances in the detection of liver tumours and characterisation |
Q38639877 | Advanced Functional Nanomaterials for Theranostics |
Q96773356 | Anthropogenic gadolinium in freshwater and drinking water systems |
Q36478976 | Application of atomic force microscopy in morphological observation of antisense probe labeled with magnetism |
Q42026547 | Augmenting regional and targeted delivery in the pulmonary acinus using magnetic particles |
Q38000520 | Biological applications of magnetic nanoparticles. |
Q28307243 | Classification and basic properties of contrast agents for magnetic resonance imaging |
Q37832178 | Clinical applications of gadobenate dimeglumine-enhanced magnetic resonance cholangiography: an expanded pictorial review. |
Q38979886 | Clinically Approved Nanoparticle Imaging Agents |
Q37503563 | Combining hyperpolarized 13 C MRI with a liver-specific gadolinium contrast agent for selective assessment of hepatocyte metabolism |
Q26768472 | Contrast Enhanced MRI in the Diagnosis of HCC |
Q28235682 | Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkers |
Q34214594 | Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer |
Q39107521 | Different cell responses induced by exposure to maghemite nanoparticles |
Q34379033 | Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging |
Q34242694 | Elemental imaging of MRI contrast agents: benchmarking of LA-ICP-MS to MRI. |
Q38155457 | Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening |
Q52883948 | Gadobutrol in the central nervous system at three doses: results from a phase II, randomized, multicenter trial. |
Q41879002 | Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis |
Q41391342 | Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice |
Q33822955 | Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent |
Q33839558 | Gd(III) functionalized gold nanorods for multimodal imaging applications |
Q53072973 | Half-dose gadobenate dimeglumine versus standard-dose gadodiamide in dynamic magnetic resonance imaging of non-cirrhotic livers: a retrospective intra-individual crossover comparison. |
Q36292525 | Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe3O4 composite as a novel nanoscale molecular probe for early diagnosis and therapy in hepatocellular carcinoma |
Q40744914 | Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging |
Q42181384 | Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging. |
Q24654739 | Imaging of liver cancer |
Q37250096 | Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations |
Q37678720 | Improved quantification of myocardial blood flow using highly constrained back projection reconstruction |
Q55467668 | In Vivo Molecular Characterization of Abdominal Aortic Aneurysms Using Fibrin-Specific Magnetic Resonance Imaging. |
Q37069946 | Introductory Chemistry: A Molar Relaxivity Experiment in the High School Classroom |
Q57185167 | MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis |
Q33847006 | Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics |
Q30841850 | Manganese doped fluorescent paramagnetic nanocrystals for dual-modal imaging. |
Q57258860 | Mesoporous silica-coated luminescent Eu3+doped GdVO4nanoparticles for multimodal imaging and drug delivery |
Q50527499 | Monitoring bone marrow-originated mesenchymal stem cell traffic to myocardial infarction sites using magnetic resonance imaging. |
Q26740054 | Multiwalled carbon nanotube hybrids as MRI contrast agents |
Q37140824 | Nephrogenic systemic fibrosis: an emerging entity |
Q33574781 | Nuclear microscopy: a novel technique for quantitative imaging of gadolinium distribution within tissue sections |
Q33852473 | Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications |
Q37755998 | Paramagnetic liposome nanoparticles for cellular and tumour imaging. |
Q58205745 | Pilot Study of Inhaled Aerosols Targeted via Magnetic Alignment of High Aspect Ratio Particles in Rabbits |
Q64252823 | Preparation and Properties of Tumor-Targeting MRI Contrast Agent Based on Linear Polylysine Derivatives |
Q81758644 | Prospects for lanthanides in structural biology by NMR |
Q40575295 | RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin |
Q30436623 | Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice. |
Q55227929 | Recent advances in non-invasive magnetic resonance imaging assessment of hepatocellular carcinoma. |
Q48107343 | Relative diffusion of paramagnetic metal complexes of MRI contrast agents in an isotropic hydrogel medium. |
Q58993973 | Renal Transplantation Is Associated with Improved Clinical Outcomes in Nephrogenic Systemic Fibrosis |
Q33415333 | Responsive MRI agents for sensing metabolism in vivo |
Q35390321 | Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study |
Q36517070 | Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging |
Q46722275 | Studies on the redox activity of iron N,O-complexes: Potential T1-contrast agents. |
Q57181647 | T-T molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents |
Q42876782 | Targeted Molecular Imaging of Antigen OC183B2 in Ovarian Cancers Using MR Molecular Probes |
Q31169933 | Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement |
Search more.